MycoTechnology raises $39 million in Series D financing

MycoTechnology closed its Series D round of financing for $39 million, totaling over $120 million. The Series D round was co-led by Greenleaf Foods, SPC, S2G Ventures, and Evolution Partners, with participation from Rich Products Ventures, Tyson Ventures, Continental Grain, Middleland Capital, Bunge Ventures, Seventure Partners, Cibus Investments Limited, and Kellogg’s eighteen94 Capital investment arm.

“We do not innovate for the sake of innovating. We create products that solve the biggest challenges in the food industry, like creating great tasting products without excessive sugar, salt, or fat and doing so in a more sustainable way,” said Alan Hahn, CEO of MycoTechnology, in a press release. “The additional funding will help bring our forward-thinking vision to reality. With many game changing products currently under development, the funds will help prepare for new product introductions that truly have the potential to change the food industry landscape and bring never-before-seen ingredients to the market.”

MycoTechnology’s flagship product, ClearTaste, is an organic bitter blocker that helps companies reduce the sugar content of their products by blocking bitterness. Their second product, PureTaste, is solving how we will feed an exponentially growing population with a sustainable, functional, and nutritional plant-based protein.